share_log

Is The Worse Over For Coraza?

Is The Worse Over For Coraza?

科拉萨的最糟情况是否已经过去了?
Business Today ·  08/24 05:24

Coraza Integrated Technology (Coraza) has maintained its BUY rating despite a challenging first half of 2024. The company has set a revised target price (TP) of RM0.62, indicating a potential upside of 48.3% from its current price of RM0.42. This adjustment follows 1H24 results that missed expectations due to weaker-than-anticipated sales and margins. The stock has faced a year-to-date decline of 3.5% and a 12-month drop of 34.4%, but analysts suggest that the recent share price weakness may have already factored in these low expectations.

尽管2024年上半年面临挑战,Coraza一体化技术(Coraza)仍然维持其买入评级。该公司设定了修订后的目标价(TP)为RM0.62,从其当前股价RM0.42来看,显示出48.3%的潜在上涨空间。此调整是基于2024年上半年未能达到预期的销售和利润率较低的业绩。该股票今年以来下跌了3.5%,12个月下跌了34.4%,但分析师表示,最近的股价下跌可能已经反映了这些低预期。

Calls by analysts at RHB reflect a mixed but generally positive outlook. The house maintains a BUY rating with a new TP of RM0.62, up from RM0.68, citing a 49% upside potential. The firm expects stronger performance in the latter half of the year, driven by a recovery in demand for semiconductor equipment. This expectation is supported by Coraza's robust customer base and its role in the front-end semiconductor supply chain.

RHb分析师的观点各不相同,但总体而言是积极的。该机构维持了买入评级,将目标价上调至RM0.62,而原先的目标价为RM0.68,预计上涨潜力为49%。该机构预计下半年表现将更加强劲,该公司在半导体设备需求恢复的推动下将取得更好的业绩。Coraza拥有强大的客户群和在前端半导体供应链中的角色,这一预期得到了支持。

The company reported core losses of RM1.7 million for 1H24, falling short of both analysts' and market forecasts. This negative deviation was due to slower sales and margin recovery. In particular, 1H24 sales dropped by 26% in both Malaysia and the US due to reduced orders, although sales in Singapore increased by 22% during the same period. Revenue for 1H24 declined by 15.7% year-on-year to RM41.5 million, affected by the semiconductor market downturn and order deferrals. Gross profit margins also fell by 6.6 percentage points to 13.1%, due to underutilisation and fixed cost absorption. However, 2Q24 revenue showed a 10.2% improvement quarter-on-quarter, reflecting a gradual recovery in the industry. The core loss for 2Q24 narrowed to RM0.3 million from RM1.4 million in 1Q24.

该公司在2024年上半年报告了170万令吉的核心亏损,未能达到分析师和市场预测。这种负偏差是由于销售和利润率恢复较慢所导致的。特别是在马来西亚和美国,由于订单减少,2024年上半年销售额同比下降了26%,而同期新加坡销售额增长了22%。2024年上半年的营业收入同比下降15.7%,达到4150万令吉,受半导体市场的下行和订单推迟的影响。毛利润率也下降了6.6个百分点,达到13.1%,原因是利用率不足和固定成本吸收。然而,2024年第二季度的营业收入环比增长了10.2%,反映了行业的逐渐复苏。第二季度的核心亏损从一季度的140万令吉收窄至30万令吉。

Looking ahead, the outlook for Coraza is positive. RHB analysts anticipate a stronger performance in the second half of 2024, supported by the resumption of orders from key customers and a general recovery in semiconductor equipment demand. The Semiconductor Equipment and Materials International (SEMI) has raised its projections for FY24, forecasting growth in the front-end, test, and assembly & packaging equipment segments. Coraza is well-positioned to benefit from this rebound, particularly with its newly acquired plant undergoing upgrades expected to be completed by 4Q24. Increased order volumes from existing and new customers are likely to enhance margins through improved operational efficiencies and economies of scale.

展望未来,Coraza的前景是积极的。RHb分析师预计2024年下半年将表现更强劲,这得益于主要客户订单的恢复和半导体设备需求的普遍复苏。半导体设备与材料国际协会(SEMI)已上调其2024财年的预测,预计前端、测试、装配和封装设备市场将增长。Coraza有望从这种反弹中受益,特别是通过其新收购的工厂进行升级,预计将于2024年第四季度完成。现有客户和新客户的订单增加可能通过提高运营效率和规模经济来提高利润率。

Despite lowering earnings forecasts for FY24F-26F due to the uneven recovery in 1H24, a more substantial recovery is expected in FY25. The revised target price of RM0.62 reflects these adjustments and maintains a 20x FY25F P/E ratio, including a 4% ESG discount.

尽管由于2024财年上半年复苏不平衡,将盈利预测下调,但预计2025财年将出现更为实质性的复苏。修订后的目标价为0.62马币,反映了这些调整,并保持了20倍2025财年预估市盈率,包括4%的esg折扣。

Source: RHB
Title: Improving Outlook; Still BUY

来源:RHB
标题:前景改善,仍可买入

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发